ArticlePatterns (New York, N.Y.)2026
Leveraging protein language models and a scoring function for indel characterization and transfer learning.
Article in Patterns (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Leveraging protein language models and a scoring function for indel characterization and transfer learning.Patterns (New York, N.Y.) · 2026Article
- Assessing structure-function impacts on Vitellogenin by leveraging allelic variant found in honey bee subspeciesiScience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein language models (PLMs) are increasingly used to assess the impact of genetic variants, achieving high accuracy and often outperforming traditional pathogenicity predictors. They enable zero-shot inference, making predictions without task-specific fine-tuning, though studying in-frame insertions and deletions (indels) remains challenging due to altered protein lengths and limited annotated datasets. Here, we present IndeLLM, a scoring approach for indel pathogenicity that accounts for sequence length differences. Our zero-shot method relies solely on sequence information, requires minimal computing resources, and achieves performance comparable to existing predictors. Building on this, we developed a Siamese network via transfer learning that outperformed all tested indel predictors (Matthews correlation coefficient = 0.77). To enhance accessibility, we provide a plug-and-play Google Colab notebook for using IndeLLM and visualizing the impact of indels on protein sequence and structure. The tool is freely available on GitHub and Google Colab.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.